Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden

समान संसाधन

• Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden
  द्वारा: Abubaker, Khalid, और अन्य
  प्रकाशित: (2014)
• Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden
  द्वारा: Abubaker, Khalid, और अन्य
  प्रकाशित: (2013)
• Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer
  द्वारा: Chan, Emily, और अन्य
  प्रकाशित: (2018)
• Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
  द्वारा: Latifi, Ardian, और अन्य
  प्रकाशित: (2012)
• Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer
  द्वारा: Samardzija, Chantel, और अन्य
  प्रकाशित: (2016)